North Dakota State University and Sanford announce the launch of research into GLP-1 medicine
FARGO, N.D. (KVRR) — Sanford and NDSU have announced the launch of research into the effects of GLP-1 obesity medication. The project is called PREDICTors of Clinically Relevant Outcomes on GLP-1 Treatment for Obesity. $210,000 has been funded for the collaboration from NDSU, Sanford Health, and the North Dakota Department of Health and Human Services. The goal of the project…
